Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the efficacy of a single dose of larazotide acetate in
preventing intestinal permeability changes induced by a 6-week gluten challenge in subjects
with celiac disease